6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate-d8 (hydrochloride)
CAT:
804-HY-W140284S-02
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
![6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate-d8 (hydrochloride) - image 1](/gentaur-product-1.webp)
6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate-d8 (hydrochloride)
- CAS Number: 1189719-74-1
- UNSPSC Description: 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate-d8 (hydrochloride) is the deuterium labeled 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate hydrochloride[1].
- Target Antigen: Isotope-Labeled Compounds
- Type: Isotope-Labeled Compounds
- Related Pathways: Others
- Field of Research: Others
- Solubility: 10 mM in DMSO
- Smiles: O=C(N1C([2H])([2H])C([2H])([2H])NC([2H])([2H])C1([2H])[2H])OC2N(C3=CC=C(C=N3)Cl)C(C4=NC=CN=C42)=O.Cl
- Molecular Weight: 419.29
- References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported